KHK 2805Alternative Names: KHK2805
Latest Information Update: 08 Jun 2016
At a glance
- Originator Kyowa Hakko Kirin
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Folate receptor 1 modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer